196results about How to "Increase alertness" patented technology

A system using passive infrared imaging of the face and other body parts of an operator to obtain observables by automatically extracting features from a sequence of images, analyzing the extracted features, and then assessing the results for indicators of performance of a task by the operator in order to provide early warning of potential cognitive or motor impairment and thereby facilitate risk reduction and quality maintenance. The infrared condition monitoring system (IR-CMS) serves to a) assess cognitive and/or physical readiness to perform a particular task; b) provide condition assessment feedback to the subject and his appropriate supervisors; c) activate measures to increase short-term alertness and other readiness factors; d) limit potential risks by restricting the subject's access, responsibility, or authority; and e) facilitate rapid medical treatment, evacuation, quarantine, re-training, or counseling as appropriate. The same condition monitoring and assessment system can also be used during training and simulator exercises to evaluate personnel for assignment.

A system for imposing a filter between a vehicle driver's eyes and a source of light including at least one detector facing inward into a compartment in the vehicle toward a likely position of the head of the vehicle driver and arranged to obtain images of the eyes of the driver and a processor coupled to the detector(s) and arranged to determine the location of the driver's eyes based on analysis of the images obtained by the detector(s) and to obtain information about objects exterior of the vehicle providing sources of light from the images obtained by the detector(s) based on reflections off of the driver's eyes, i.e., the position of such objects. A filter, such as a pixelated screen, is imposed between the sources of light and the driver's eyes based on the location of the driver's eyes and the information about the exterior objects providing the sources of light.

Apparatuses (e.g., devices, systems), and methods for transdermal electrical stimulation (TES). Apparatuses described herein can be self-contained, lightweight, and wearable. The apparatuses and methods described herein be configured to apply an ensemble current waveform between the two or more electrodes, wherein the ensemble current waveform comprises a series of component waveforms that are sequentially applied, and wherein each component waveform is different from a component waveform immediately before it and wherein transitions between the component waveforms temporally correlates with transitions in the sensory experience. Also described are neurostimulators for application of transdermal electrical stimulation (TES) and methods of using them for comfortably inducing a cognitive effect. Also described are Methods and apparatuses for amplitude modulation of all or a portion of an ensemble waveform to modify a user's cognitive state by transdermal electrical stimulation (TES).

A novel sleep regulating pharmaceutical formulation is introduced, typically implementing two principal drugs having actions which are reversive to one another, yet incorporated into a unitary solid dosage, and prepared for oral administration before bedtime. Usually, structure is configured to initially release a calmative or other sleep-compatible substance by prompt dissolution. The initial release is followed by a specific period of delay, which in basic formulations entails no release of any drug, and which allows a nominal interval of sleep. At the terminus of the delay, a final agent is released to induce wakeup. Incorporation of agents of opposite action within a unitary dosage form renders utility which is uniquely appropriate to the invention. In a preferred embodiment, delay of release and final delivery of wakeup agent are arranged by a dialysis membrane which eventually bursts as a result of osmotic pressure generated by a hydrophilic core.

A lighting system for initiating change in a mammal's circadian or well-being state includes a computational unit configured to receive state information regarding the mammal's circadian or well-being state, and operational information from a light sensor with spectral and luminosity sensitivity. The computational unit is configured to compare the operational information with the state information, and on the basis of this comparison, the computational unit outputs a control signal to a light control unit which, in turn, adjusts a controllable light source to vary its light output so as to initiate the desired change in the mammal's circadian or well-being state.

Methods of modifying a subject's cognitive state by applying transdermal electrical stimulation (TES). In particular, described herein are methods of applying TES using a pair of electrodes each positioned at a particular location on the skin of the subject's head, or the head and neck, to evoke a predetermined cognitive state using a TES applicator. In particular, described herein are methods of enhancing attention, alertness, or mental focus or of enhancing a calm or relaxed mental state by applying high-intensity TES across electrodes positioned on the subject's temple and either the mastoid region or on the subject's neck. The subject may control the application directly and TES may be applied by a portable, including wearable, TES applicator.

A wearable signal acquisition and computerized display device including at least one first sensor configured to measure at least one of the following attributes from a subject wearing the device: attention, focus, concentration, alertness, and mood. The device has a heads-up display or goggles, glasses, or another head piece having lenses. The measurement is derived from the subject's brainwaves by use of one or more algorithms. The subject wearing the device receives neurofeedback data based on this measurement through the projected image to train them how to control attention, mood, etc. and improve understanding as to how various external stimuli in the real world or virtual world impact these attributes. In one variation the sensors measure brainwave signals at two positions of the subject and use the difference in these measurements to derive an attention indicator signal used to provide neurofeedback.

This invention provides compositions, methods and process of producing extracts and pure compounds from Xanthoceras sorbifolia. The extract comprises saponins and other constituents including alkaloids, coumarins, saccharides, proteins, polysaccharides, glycosides, tannins, acid, flavonoids and others. The composition can be used for treating cancer and other conditions, such as arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, headache, kidney disorder, and impotence; for improving cerebral functions; or for curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease, autism, brain trauma, Parkinson's, cerebral dysfunctions, and treating arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, headache, dizziness, kidney disorder. This invention provides compounds of oleanene triterpenoidal saponin in nature with the characteristics that at least one angeloyl group attache to Carbon 21 or/and 22, or/and linked to the sugar. The compounds of the present invention have various pharmaceutical and therapeutic applications.

Portable transdermal electrical stimulation (TES) applicators for modifying a subject's cognitive state. In general, the portable applicators described are specifically configured and adapted to be lightweight and may be wearable, and to deliver a high-intensity TES able to evoke or enhance a predetermined cognitive effect. These TES applicators may include a pair of electrodes and a TES control module comprising a processor, a timer and a waveform generator. TES control module is adapted to deliver a biphasic electrical stimulation signal of 10 seconds or longer between the first and second electrodes having a frequency of 400 Hz or greater, a duty cycle of greater than 10 percent, an intensity of 3 mA or greater, with a DC offset.

An alertness inducing composition contains the active ingredients caffeine and taurine and various inert substances in a dry formulation. Caffeine and taurine are delivered in an oral formulation that obviates the need for ingesting significant quantities of liquid or sugar.

The current invention provides methods of enhancing a subject's attentional state. The methods comprise a series of interactive behavioral assessments and interactive behavioral training sessions, which trains the individual to be in a more optimal attentional state throughout their day-to-day life, ultimately enhancing their cognitive performance, visuomotor performance, and emotion regulation.

This invention provides systems and methods of supplying oxygen-enriched air to an enclosed space or compartment. The systems and methods may distill oxygen from ambient air by a molecular sieve pressure cycle mechanism, such as a pressure swing absorption, may generate oxygen from water using electricity or may use oxygen enriched air produced by membrane filtration. The invention helps people improve their wellness, productivity and comfort, improve performance of mental and/or physical tasks, increase their alertness, quality of life and pleasure, reduce their drowsiness, and aid in curing and preventing disease by increasing the percentage of oxygen in the enclosed space to a beneficial and safe level.

The invention discloses a ship collision risk analysis method based on AIS (automatic identification system) data. Based on historical AIS data and standard ship selection and conversion, a density clustering algorithm is used for establishing a heat map of a ship collision risk to realize spatiotemporal visualization of the ship collision risk; based on real-time AIS data and the ship position field, the course direction field, and the navigational speed field, a regional ship collision risk assessment model is constructed, and a Gaussian kernel function kernel density estimation algorithm isused for proposing a dynamic ship collision risk visualization method to realize areal-time update of the regional ship collision risk. The ship collision risk analysis method is based on the AISdata,the spatiotemporal visualization of the ship collision risk is realized,the visual image after the complex abstract ship traffic flow multi-attribute information is effectively dug and fused is realized, so that the risk level of the environment of the location of the ship can be intuitively and conveniently obtained by a driver or an operator, thusself-alertness is improved, the reasonable control measures are taken, and the safe operation of the ship is ensured.

A light fixture, e.g., as an artificial skylight, in which light within a region defined by x, y color coordinates (0.37, 0.34), (0.35, 0.38), (0.15, 0.20), and (0.20, 0.14) exits a first light engine, and light within a region defined by coordinates (0.29, 0.32), (0.32, 0.29), (0.41, 0.36), (0.48, 0.39), (0.48, 0.43), (0.40, 0.41), and (0.35, 0.38) exits a second light engine. Also, light fixtures in which a second light engine comprises a sidewall, and light exiting a first light engine passes through space defined by the sidewall; light fixtures in which first and second light engines are able to output light providing different CS values at a luminance; light fixtures in which light incident on a surface of the fixture and cumulative light exiting the fixture have different color points; light fixtures in which light distribution characteristics of light engines differ; and/or other features. Also, methods.

The invention provides a three-channel lighting apparatus with the option to support the human circadian rhythm. By choosing especially the blue LED and green phosphor, the range of biological activity that can be changed is optimized. By adjustment of the LED spectra a bigger range in melanopsin effectiveness factor, at the same CCT range (from daylight like CCT down to dimmed halogen), can be obtained.

The present invention relates to a foam pad containing far-infrared and/or ion generating particles and method for producing such foam material. The method for producing the foam pad consists of mixing fine particles of a far-infrared and/or ion emitting stone into the base material prior to further processing such as forming, molding or extruding the material. Alternatively, the fine particles of far-infrared and/or ion generating stone may be mixed with an adhesive and used as a coating on the foam pad. The stone generating far-infrared radiation and/or ions is preferably from the group consisting of tourmaline, granite porphyry, quartz porphyry, zeolite, perlite, serpentine, or mixture thereof.

An upright active-sitting seat provides a connection of a seating leg to a base through an articulating joint that allows the user to move a seat front to back and side to side, allowing a more active sitting that encourages blood circulation. The chair includes a seat supported by a post that is connected to a mount via a ball joint rod by a transverse rod that is routed through the ball joint rod end. By way of a coil spring that engages with the mount and the post, the post is spring biased to a home position relative to the mount. When using the chair, a person may move the seat from the home position to a comfortable seating position. When the person stands from the chair after using it, the chair returns to its spring biased home position.

Chewing gum compositions comprising synephrine, ephedrine and caffeine are provided. The compositions are useful for supporting thermogenesis and anorectic effects, while generating enhanced mental alertness and improved energy levels.

Lighting systems, methods, and devices for protecting human circadian neuroendocrine function during night use are described. Suitable lighting conditions can be provided for a working environment while protecting the circadian neuroendocrine systems of those occupying the illuminated workplace during the night. Lighting systems, methods, and devices can provide substantive attenuation of the pathologic circadian disruption in night workers. Lighting systems, methods, and devices can attenuate the specific bands of light implicated in circadian disruption. LED lighting systems, methods, and devices can provide increased intensity at a different portion of the spectrum than conventional LEDs, providing a useable white light even when unfavorable portions of the wavelength are attenuated by a notch filter. LED lighting systems, methods, and devices can switch between a daytime configuration and a night time configuration, wherein the daytime configuration provides unfiltered light and the night time configuration provides filtered light.

A method to warn of a vehicle moving in the wrong direction of travel, wherein in a provision step, a third-party warning message is provided for other road users when at least one wrong-way-driver signal signals wrong-way travel of the wrongly moving vehicle sensed using a wrong-way-driver sensing method, and in an output step, a self-warning message is output for a driver of the vehicle moving in the wrong direction of travel when the wrong-way-driver signal signals the sensed wrong-way travel and at least one further wrong-way-driver signal signals the wrong-way travel of the wrongly moving vehicle sensed using a further wrong-way-driver sensing method, the further wrong-way-driver sensing method differing from the wrong-way-driver sensing method.

The present invention relates to a process to produce a composition comprising water-soluble peptides and having a Trp/LNAA ratio of more than 0.15, which comprises hydrolyzing lysozyme, preferably hen eggs lysozyme, to prepare a hydrolysate having a DH of between 5 and 45.

Substituted 3-pyrrolidine-indole derivatives and methods for their production. Also pharmaceutical compositions containing these compounds and the use of these substances in methods of treatment, in particular treatment of pain and/or depression.